ARTICLE | Clinical News
EllaOne ulipristal regulatory update
June 1, 2009 7:00 AM UTC
The EC approved an MAA for ellaOne ulipristal for use as an emergency contraceptive up to 5 days after unprotected intercourse. HRA plans to launch the selective progesterone receptor modulator (SPRM...